Explore every episode of the podcast High Truths on Drugs and Addiction

Hope vs Handcuff is what Judge Linda Davis recommends for people with a substance use disorder.

Judge Linda Davis was appointed to the bench on March 27, 2000, by Michigan Governor John Engler. Prior to her judgeship, she spent 13 years as an Assistant Prosecutor with the Macomb County Prosecutor’s Office. Davis played a crucial role in the creation of Face Addiction Now, formerly Families Against Narcotics and has been instrumental in the success and growth of the organization. She has received several prestigious awards from organizations such as the FBI, Care House, and the Girl Scouts of America. Among the awards she has been given are the Macomb Community College Outstanding Alumna Award; the Michigan Association of Treatment Court Professionals President’s Award; the Macomb Bar Distinguished Public Service Award; and the Macomb County Humanitarian of the Year Award. She has also been named the Henry Ford Hospital Woman of Excellence and Influence and the 2019 Community Star for the state of Michigan in conjunction with National Rural Health Day.

Judge Davis served on Michigan Governor Rick Snyder’s Opiate Task Force and later was appointed to chair the Governor’s Commission for the Prescription Overdose and Opiate Response Team. In addition, she was invited to consult with President Donald J. Trump’s Opiate Task Force and First Lady Melania Trump’s roundtable discussion on how the opioid epidemic is affecting families. Davis’ expertise was also called on by Michigan Governor Gretchen Whitmer, resulting in a spot on the state’s Opioid Task Force Advisory Board. Davis is currently FAN’s Executive Director and primary speaker and presents multiple times a week to groups—both statewide and nationally—on the opioid crisis and the stigma associated with addiction. A frequent plenary speaker at conferences, she works tirelessly to educate doctors, nurses, dentists, law enforcement, lawyers, and legislators about substance use disorder.

Davis’ recent presentations include those made to Impact100; the Michigan Association of Treatment Court Professionals Conference; the Michigan Rural Health Conference; the Michigan Department of Corrections; the Opioid and Substance Use Disorder Virtual Summit; the Police Treatment and Community Collaborative’s Pre-Arrest Diversion Summit (Chicago); the CDC/HIDTA Overdose Response Strategy Conference (Salt Lake City); and the Southern Nevada Substance Misuse and Overdose Prevention Summit (Las Vegas), Keynote speaker for National Rural Health conference (Washington D.C.  Presently working on an initiative to take FAN’s programming to rural areas of Michigan, Davis was recently appointed as a voting member of the new Opioid Advisory Commission in Michigan, which will determine how funds from the National Opioid Settlement will be spent in the state.

Disclaimer:  The views and opinions expressed in this podcast are solely those of the speaker and do not necessarily represent the views, policies, or positions of the United States Government or any of its agencies. The content was recorded prior to the speaker's current federal service and is provided for informational and entertainment purposes only.  No agency endorsement or approval should be inferred.

There has been a complete reorganization of the Health and Human Services Department.  What has remained, what has been DOGED?  What happened to SAMHSA, CDC, NIDA, FDA and key agencies that are important to the prevention, treatment, and recovery of drugs. What about payment for addiction services and medical care? How does all that affect the average American or organization that deal with drug issues. To learn more about the reorganization of HHS I reached out to Jeffrey Davis.

Jeffrey Davis is a skilled healthcare executive with substantial knowledge of regulatory advocacy and healthcare policies. Jeffrey’s work focuses on issues tied to provider payment and reimbursement as well as quality reporting. He also has significant experience with recent regulatory developments such as the implementation of surprise billing rules.

Jeffrey is the primary author of Regs & Eggs, M+’s weekly regulatory affairs blog. To browse blog entries and subscribe to updates, click here.

Prior to joining McDermott+, Jeffrey served as the director of regulatory and external affairs at the American College of Emergency Physicians (ACEP). In that role, Jeffrey managed ACEP’s formal response to federal policies and worked with federal agencies and other stakeholders to help advance ACEP’s federal affairs agenda.

Jeffrey also spent eight years working with the US Department of Health and Human Services, where he advised senior officials on major budgetary and policy considerations within Medicare and prepared detailed analyses of Medicare regulations and legislation.

*** Disclaimer:  The views and opinions expressed in this podcast are solely those of the speaker and do not necessarily represent the views, policies, or positions of the United States Government or any of its agencies. The content was recorded prior to the speaker's current federal service and is provided for informational and entertainment purposes only.  No agency endorsement or approval should be inferred.

iPill - a devise to ensure medication compliance. Is this something that methadone clinic patients can use to ensure safety?

Dr. John Hsu has practiced anesthesia, chronic pain management, addiction medicine for 31 years.  He is now on a quest to address the opioid epidemic. He has started three companies, including:

IPill Dispenser - a medical device for remote medication adherence monitoring. It is a FDA breakthrough designated product and holds six patents for it.

Quivive Pharma - drug development company that has combined opioids with a respiratory stimulant. He is running a clinical trial at the Cleveland clinic and a supported by a $1.9 million NIDA/NIH grant.  He holds three patents for this company.

Fentavive - a drug development company that has combined Narcan with a respiratory stimulant to address dosing ambiguity with Narcan. He holds one patent for this company. 

Drug Endangered Children - 1 in 8 children live with one or more caregiver with a substance use disorder in the United States. Millions of children and families are affected by parental or caregiver legal and or illegal substance misuse today.  759,000 children experienced a parental death due to drugs from 1999-2000.

Dr. Lev discussed drug endangered children and solutions with Eric Nation.

National Alliance for Drug Endangered Children

Executive Director

Eric Nation spent over 20 years in the field of law enforcement where he worked his way

up to Lieutenant. As a Lieutenant, he led a large successful drug task force and started a

countywide Drug Endangered Children Alliance. Mr. Nation came to National DEC to

have a greater impact on law enforcement and other professionals by training and

educating them on substance misuse and the impact to children. Mr. Nation was the

Director of Training and Development where he helped develop curriculum and

materials, worked with agencies across the country to provide trainings and technical

assistance to professionals. Mr. Nation is also a national trainer on various topics

including substance use, law enforcement, building multidisciplinary teams, capacity

building, and drug trends. Mr. Nation is currently National DEC's Executive Director

impacting change at a different level. Mr. Nation is very passionate about helping

children and brings passion to every part of the work he does across the country.

Unspeakable violence happened in 2018, when a 28 year old professional audiologist, Bryn Spejcher, was on a date with a 26-year-old accountant, Chad O'Melia.

Chad was a regular marijuana user with a large bong displayed on his coffee table. 

Bryn inhaled the THC from the bong and within minutes developed cannabis induced psychosis.

Having severe hallucinations, Bryn stabbed Chad 108 times, using kitchen knives. She also stabbed her beloved service dog and then repeatedly stabbed herself in the neck, nearly killing herself.

Bryn is doing community service for involuntary manslaughter. She joins High Truths with her mother and Aubree Adams.

Aubree Adams is the founder and director of Every Brain Matters, a nationally trusted educational resource formed by families with loved ones whose lives were damaged or ended by marijuana. Every Brain Matters has a memorial to the many lives lost to marijuana. She hosts her own podcast, "It's Just pot, what's the problem?" She returns to High Truths from Episode # 170.  

High Truths discussed the Bryn Spejcher manslaughter case of Chad O'Meilia on previous episodes on High Truths.

On episode #163 we spoke with Heidi Swan and Dr. Christy Brown who attended Bryn's trial and discussed the trial.

On episode #172 we spoke with Eve Simmon, a reporter from the Daily Mail who reported on the trial. She empathized with Bryn.

Hello again High Truths Listeners. Get ready for a special podcast.

It’s special... and a little emotional. Because I have some big news to share with you.

So let’s start with the tough part first. The bad news is... I’m going to need to hit pause on the High Truths podcast for now. High Truths is one of my most favorite projects.  I love talking to you and I learn so much from my guests. We learn together and inspire action to make things better around us.

I will really miss you and High Truths.

But here’s the good news — and it’s really good: I’ve been offered — and accepted — a position back at the White House Office of National Drug Control Policy, ONDCP.

Listen to my special message.

HIDTA published its 2025 Marijuana's Impact on California Report.

In 2022, 43% of suicides among individuals 25 and under in San Diego County involved THC.

Emergency visits due to marijuana rose by 521% in California from 2008 to 2022.

Youth aged 12–17 accounted for nearly 38% of marijuana treatment admissions in 2023.

High-potency cannabis is increasingly linked to psychosis and cannabis use disorder.

Executive Director David King join High Truths to discuss HIDTA and the report.

David King was appointed Executive Director of the San Diego Imperial Valley HIDTA ni 2017 after 28 years of law enforcement service with the California Department of Justice/ Bureau of Narcotic Enforcement (DOJ/BNE) and San Diego Harbor Police Department. Mr. King is a graduate of the University of San Diego with a Bachelor of Science (B.S.) degree in Political Science, and he attended the FBI National Academy (FBINA) 240th Session in Quantico, Virginia. Mr. King began his law enforcement career with the San Diego Harbor Police Department in 1989 where he worked a variety of patrol assignments before being selected as the first task force officer ni the department's history to investigate narcotic and bulk currency smuggling at the San Diego International Airport. Mr. King received state and federal recognition when he was named by Harbor Police, Peace Officer of the Year, in 1995. Mr. King was hired by the California Department of Justice/ Bureau of Narcotic Enforcement ni 1997, and he served on the Clandestine Laboratory Program, Special Operations Unit and supervision of multi-agency narcotic task forces. Mr. King promoted to Special Agent in Charge where he expanded wire intercept capabilities and mission readiness for federal, state and local law enforcement agencies combating drug trafficking organizations operating along the U.S./Mexico Border. During Mr. King's tenure with the California Department of Justice he served as Senior Special Agent ni Charge of regional offices located ni San Diego, Riverside, Orange and Los Angeles before retiring as the Executive Director of L.A. IMPACT comprised of 50 federal, state and local law enforcement agencies and is credited with being the largest domestic task force in the United States. During Mr. King's tenure at L.A. IMPACT, his teams were the recipient of three national HIDTA Awards, and he is the recipient of the California Attorney General's Award for Excellence as a Team. Mr. King is a lifetime member of the California Narcotic Officers Association (CNOA), National Narcotic Officers Association Coalition (NNOAC), currently serves as an elected member of the National HIDTA Directors Association (NHDA), and he is honored to work with over 800 dedicated federal, state and local law enforcement officers, intelligence analysts and prosecutors who are assigned to HIDTA task forces in San Diego and Imperial Counties.

Mar-Anon is an important support group for people who have loved ones addicted to marijuana. Mar-Anon is based on the same concept of Al-Anon for alcohol. While AA and MA are for people with a substance use disorder, Al-Anon and Mar-Anon are for families.

In keeping with the anonymous aspect of the organization, I am just using Bart's first name.

Bart was a summer camp counselor, camp director and teacher, earning his Teaching credential from Chapman University.  After retiring from teaching he started volunteering with Mar-Anon, Every Brain Matters and other educational non-profits.  Bart used to think marijuana was harmless. “When I was smoking weed in my 20’s I used to say stuff like, “it’s just pot, it’s not a big deal.” Marijuana was a very big deal for his son, Kevin. Bart witnessed his son experience many episodes of Cannabis Induced Psychosis.  Kevin died by suicide in 2018 at 29 years old.  The last articulate words Bart heard him speak were, “Cannabis has ruined my life.”

Resources: 

Mar-Anon - for supportive meetings

Every Brain Matters - for facilitated meeting

There are different opinions on smart drug policies. Some want to decriminalize all drugs, some promote all drug legalization, and there is drug commercialization. What is the balanced approach from international experts? Luke Niforatos with Foundation for Drug Policy Solutions discusses what an expert panel recommends.

Luke Niforatos serves as the Executive Vice President of Smart Approaches to Marijuana (SAM) and the Foundation for Drug Policy Solutions (FDPS) and is widely recognized as one of the nation’s leading drug policy experts. Leveraging more than a decade working on drug, addiction and health care issues, Luke drives the strategy behind FDPS & SAM’s federal, state, and educational initiatives. Luke has testified in state capitols across America. He is a sought-after guest on major media outlets including ABC, Fox News, NBC, CNBC, CSPAN, Newsmax, and network affiliates, as well as syndicated and local radio shows in markets coast to coast. Luke has been featured in Time Magazine and as a speaker at drug policy events held by The Economist, the United Nations’ Commission on Narcotic Drugs, and hundreds of town halls. Prior to joining SAM, he was the co-founder of a successful healthcare company. Luke attended the University of Denver and has a Master of Arts from Johns Hopkins University. 

@learnaboutsam

@gooddrugpolicy

@lukeniforatos

Learnaboutsam.org

Gooddrugpolicy.org

Marijuana is addictive, especially with the high potency products. And with addiction come withdrawal. Withdrawal of THC is not like withdrawal from fentanyl or alcohol. It is more like withdrawal from nicotine - insomnia, anxiety, headaches. The symptoms last about 2 weeks and there are no medications to help. However, going up the FDA rapid approval pathway is a new medication. We talk about this treatment in this podcast.

Ginger Constantine, M.D. is the Chairperson, Co-Founder & CEO of PleoPharma.

Ginger Constantine, MD – Chairperson and CEO - with over 25 years of pharmaceutical regulatory and clinical development experience with the approval of more than 15 products filing numerous INDs, NDAs, and MAAs. Previous Vice President of Women's Health & Bone Repair Clinical Research at Wyeth Pharmaceuticals through its acquisition by Pfizer in 2010. Expertise in Phase 1 through 4 clinical development strategy and execution. 

​

Founded EndoRheum Consultants in 2010, a successful clinical development consulting firm. Member of multiple scientific advisory boards. Has planned, authored and presented numerous scientific studies.

PheoPharma was granted fast-track designation for PP-01, a new investigational drug for cannabis withdrawal syndrome. 

Jamie Ross wears many hats.  She is Executive Director of the PACT Coalition, coordinator for the Nevada Statewide Coalition Partnership and sits on too many boards and committees to count.

Jamie Ross has been the Executive Director of the PACT Coalition since 2011. She has been involved with substance misuse prevention from a young age, and took that passion into a career creating system wide change to reduce substance misuse. 

The PACT Coalition is a substance misuse prevention coalition in Las Vegas with diverse funding focusing on the spectrum of prevention including mental health, primary and tertiary substance misuse prevention, and the intersection of prevention into all aspects of community building.  

Jamie believes in the power of community to change itself for the better. When a community comes together to solve its own problems, the result is transformative.  As Sam Quinones says, ‘the solution to the opioid crisis isn’t naloxone, it’s community.’ 

Communities can and should lead in creating an environment that prevents addiction. It is much easier to prevent a problem than treating a problem. One high level prevention initiative is fixing the Farm Bill that opened up the door to a new type of poison on Americans. The various intoxicating Hemp products, Delta-8, Delta-10, and others, have never been tested on rats, let alone kids. Sue Thau has been leading the charge in fixing the Hemp loop hole.

Sue Thau is a Public Policy Consultant representing Community Anti-Drug Coalitions of America (CADCA). She is nationally recognized for her advocacy and legislative accomplishments on behalf of the substance abuse prevention field. She has an extensive background in public policy and has held high positions at the federal, state, and local levels. She was a Budget Examiner and Legislative Analyst at the Office of Management and Budget, in the Executive Office of the President for over ten years. Sue was a driving force behind the passage, reauthorization and full funding of the Drug-Free Communities Act. In addition, Sue has worked to save and enhance funding for all federal substance abuse prevention and treatment programs over the last two decades. She is highly respected as an expert on demand reduction issues by members of Congress and staff on both sides of the aisle on Capitol Hill. Sue has an undergraduate degree from Cornell University in Human Development and Family Studies and a Master’s Degree from Rutgers University in City and Regional Planning.

The students at the San Diego State University Graduate Program in Homeland Security use this High Truths podcast as part of their curriculum.

Robert J. Harkins, MS, is a Lecturer and Academic Advisor (Lastnames: A-M) for the Graduate Program in Homeland Security.  Professor Harkins has extensive Homeland Security public safety expertise specializing in offenses and conspiracies involving United States Code, Title 21, Food and Drugs (Controlled Substances Act), and governmental managerial experience, to include investigative planning, critical thinking, and oversight of personnel and programs. Mr Harkins is extremely involved with organizations and associations focused on the networking of professionals in the public safety and public health sectors. 

As an Adjunct Faculty member with the Homeland Security Graduate Program, Mr. Harkins led a major effort to secure external grant support for teaching about Fentanyl to the San Diego County region on multiple levels, and helped design and build demonstration products for a major grant proposal to the CDC that was prepared and submitted via the SDSU Research Foundation. Mr. Harkins works with regional leaders in helping move Fentanyl and opioid abuse awareness to regional, state, and national leaders, and to many people serving in the law enforcement and social services community responding to the opioid epidemic.  

Mr. Harkins represents SDSU and the Homeland Security Program in regular meetings with community leaders, law enforcement leaders, and social service leaders responding to the alarming number of overdose deaths in San Diego County. Mr. Harkins has taught about Fentanyl including the design of Fentanyl education programs for middle school and high school as well as adults. These meetings with community leaders led to the creation of the Community Response to Drug Overdoses (CReDO) subcommittee, which is supporting a mandate by the San Diego County Board of Supervisors to create a Fentanyl education curriculum for all schools in San Diego County along with Narcan/Naloxone distribution. 

Mr. Harkins' ability to provide compelling teaching is from the hundreds of teaching episodes he has had in contacting community members, as well as teaching them how to recognize Fentanyl poisonings and then how to appropriately respond. These teaching experiences have given him a profound ability to communicate to a wide variety of people in a compelling way, which has almost certainly saved many lives in the region. Mr. Harkins uses this same teaching experience in teaching and advising of graduate students in the Homeland Security Graduate Program. 

Sean Hemeon is an actor (911, Criminal Minds, True Blood, CW’s the Husbands), writer and artist. Originally from Northern Virginia, he now lives in Los Angeles with his husband and two Bostons. Sean will have his debut memoir The Good Little Druglord, the inspirational story of a (former) Mormon drug dealer who found redemption as a narc for the federal government—confronting the Russian Mafia, his darkest self, his mother, and the mother of a young man who died because he failed to act. 

The Good Little Druglord is an ode to redemption, recovery, and the mother/son bond—an ultimately UpLit memoir about a gay Mormon drug-dealing narc for the federal government.

           As a drug-dealing meth addict, I embraced my “darkness,” claiming my place among the worst of God’s beasts until my deeper humanity was challenged, when someone died because I failed to act. It was the call from the dead boy’s mother, begging to know what happened, that shattered me.

          I wrote this book to let that grieving mother know what happened to her son, and to let my own mother know what happened to her son. I also wrote this book for those struggling with identity, and for those who care about them. 

I believed I was a decent human, until I was confronted with the reality I was not. I believed I deserved every horrible thing that had happened in my life: abandonment, molestation, and beatings. I deserved to go to prison or be murdered by the volatile Russian Mafia meth supplier to whom I owed thousands of dollars.

          Like many others, maybe you, I spent too many years of my life engaged in a futile battle for self-love and acceptance. As long as I believed I was the cause for the lack, it would always feel like chasing rainbows (or running from them in my warped Mormon case). I picked up beliefs in my childhood from my parents, society, and religion that shaped a false identity. 

It was my fault my depressed mother didn’t love me, so I tried to be the best little Mormon boy I could be. When that failed, I became her worst fear: a hedonist, raging faggot, drug-dealing narc. I rejected the authentic parts of myself, and forced the “acceptable” to be effective until it wasn’t, leading to an implosion.

          It took me nearly twenty years to get here, journaling to find my way as I fought to be loved. I wore this story like a badge of honor in recovery, like a masturbatory glory piece. I wallowed in victim-y stuff, abating shame, but now, the shame is healing. 

I’ve shared my narrative, not just for the collective but to remember myself. It has become my superpower: Never forgetting my addiction makes whatever happens today a bonus, no matter how low I feel.

          There are other accounts of addiction, religious abuse, sexuality, and even gay boys and mothers, but few are wrapped in a riveting tale about a drug-dealing narc for the federal government evading the Russian Mafia. It’s identity and acceptance wrapped in a thriller.

Perhaps by the end, there may be hope for a drug-addicted loved one, or yourself if you need the help. I hope this story helps you see that you and those you care about can live through your worst fears and nightmares. You, too, can be a mother-effing dandelion fighting to grow through the cracks. You, too, can also make peace with your mother, or her memory. 

           My mother proudly walked me down the aisle at my very gay wedding and applauded when I kissed my new husband. 

           By the end of this, you’ll want to hug your mother, too.

Lori Jane Gliha is an award winning investigative reporter with Scripps News. She is also the nation's expert in tracking pediatric fatalities due to fentanyl. She joins us to share her experience. This is an episode you may want to watch on You Tube to view some of Lori Jane's video clips. The show notes have links to reports.

Lori Jane Gliha is an ethical, enterprising, award-winning national investigative reporter for Scripps News. She is known for her exclusive, national, in-depth investigations, hard-hitting interviews, and continuous coverage of important issues including the use of ketamine - by paramedics -to sedate agitated people; fentanyl poisonings among babies, toddlers, and young children; and gun violence. In 2025, she was awarded the prestigious duPont-Columbia Award for her investigation into the deadliest mass shooting of 2023 in Lewiston, Maine. She has received two national Edward R. Murrow Awards and has been awarded the highly competitive IRE award for longform video journalism, a national recognition for investigative reporters and editors. She received a degree in Broadcast Journalism at the University of Southern California, and graduated, Summa cum Laude, as the Outstanding Broadcast Journalism Undergraduate. She minored in Spanish.

Scripps News Investigates: The silent toll of the fentanyl epidemic. Nov 2023

How a 5-year-old ingested fentanyl in her kindergarten classroom

Poisoned: Fentanyl's Child Victims march 2025

He was gasping for air: How witnesses describe child fentanyl poisonings

Colorado Gov Jared Polis 'disheartened by communication gaps in child fentanyl cases

Twin babies and parents saved following hospital fentanyl test

States push for life saving fentanyl testing laws amid rising opioid concerns - April 2025

Many Child fentanyl deaths remain uncharged, Scripps News review finds

Fentanyl Pipeline: How a Chinese Prison Helped Fuel a Deadly Drug Crisis in the United States - we discuss this publication in ProPublica and much more in a fascinating discussion with Sebastian Rotella.

Sebastian Rotella is an award-winning foreign correspondent, investigative reporter and novelist. His reporting has taken him across the world to more than 30 countries. Since 2010, he has been a senior reporter at ProPublica covering international security issues such as organized crime and intelligence. His honors include a Peabody award, multiple awards from the Overseas Press Club, Columbia University’s Moors Cabot Prize for coverage of Latin America, and Italy’s Urbino Press Award. He is a two-time finalist for the Pulitzer Prize. Sebastian is also a critically-acclaimed author of three novels: Rip Crew (2018), named one of Kirkus Review’s best crime novels of the year; The Convert’s Song (2014), an editor’s pick on Amazon; and Triple Crossing, the New York Times Sunday Book Review’s favorite action thriller and debut crime novel of 2011. He is also the  author of Twilight on the Line: Underworlds and Politics at the U.S.-Mexico Border (1998), named a New York Times notable book. He has been an invited speaker at the FBI, the Office of the Director of National Intelligence, the U.S. Army, the NYPD Intelligence Division, and U.S. and foreign embassies, think tanks and universities. His coverage of the U.S. Mexican border inspired two songs on Bruce Springsteen’s album The Ghost of Tom Joad.

Rotella articles of interest:

https://www.propublica.org/article/china-fentanyl-prison-yafeng-illegal-drug-trade

https://www.propublica.org/article/chinese-organized-crime-us-marijuana-market

https://www.propublica.org/article/oklahoma-marijuana-china-diplomat-visits

https://www.propublica.org/article/marijuana-oklahoma-china-immigration-safety-workers

https://www.propublica.org/article/china-cartels-xizhi-li-money-laundering

https://www.propublica.org/article/liu-tao-trump-meeting-china-investigation

https://www.propublica.org/article/how-beijing-chinese-mafia-europe-protect-interests

Carlton Hall Consulting LLC (CHC) – Driving Global Change Through Community Solutions and Prevention Mastery

Carlton Hall Consulting LLC (CHC) is a dynamic, full-service consulting firm dedicated to providing customized solutions that drive measurable change for communities, organizations, and individuals. With a mission to solve complex social challenges and improve the human condition, CHC delivers expert training, technical assistance, and capacity-building services to clients in both the public and private sectors at local, national, and international levels.

As a co-owner of Prevention Mastery, CHC is at the forefront of professional development in the prevention field. Prevention Mastery is a cutting-edge, customizable online Learning Management System (LMS) that provides a suite of enhanced consultative services tailored for prevention professionals at the federal, state, regional, local, and international levels. Designed to streamline digital learning, Prevention Mastery consolidates e-learning needs into a single, comprehensive platform—offering automated training assignments, completion records, version control, and tracking. Through expert-led, self-paced courses, Prevention Mastery equips prevention professionals with actionable, data-driven strategies to drive change and leadership in the field.

Led by President and CEO Carlton Hall, CHC has been a leader in substance abuse prevention, capacity building, and community problem-solving for over 25 years. Carlton’s work spans four continents, partnering with global organizations, national governments, and grassroots coalitions to advance prevention science and demand reduction efforts. CHC has played a key role in international initiatives, including collaborations with the United Nations Office on Drugs and Crime (UNODC), the Colombo Plan, and the African Union, and has supported groundbreaking conferences and training programs in Kenya, India, South Africa, Zambia, Nigeria, and Uganda.

Committed to culturally responsive solutions, CHC has launched impactful global programs such as the Global Youth Prevention Scholars Initiative (GYPSI) and the NHIF Initiative in Kenya, which provided life-changing healthcare access to over 116 women and their families. CHC continues to shape global prevention efforts through executive training, technical assistance, and capacity-building support, including its work with SAMHSA’s Southeast Prevention Technology Transfer Center (PTTC, Region 4). Carlton Hall also serves as President of the National Alliance for Drug Endangered Children (NA-DEC) and sits on the board of Movendi International, further amplifying CHC’s influence in shaping sound drug policy, advancing prevention science, and strengthening community-led solutions worldwide.

Dr. Mark Gold gives a historical perspective on field of addiction from the original research of the brain disorder to current events.

Dr. Mark Gold is a frequent contributor to Psychology Today.

Dr. Mark Gold is an inventor, pioneering translational researcher, Eminent Scholar, Distinguished Professor, & Chairman whose career in translational neuroscience began in 1972. His theories have changed the field, stimulated research, and led to new treatments. Gold, while at the YSOM, proposed a novel brain mechanism and changes to explain opioid dependence and withdrawal, and discovered the anti-withdrawal efficacy of alpha-2 adrenergic agonists-clonidine and lofexidine. With his Yale colleague & mentor Herb Kleber, Gold helped change addiction psychiatry to disease management, evidence-based care with MATs, and evaluation & treatment of co-occurring disorders. He has made major contributions to Naloxone in overdose and Naltrexone and agonist therapies in OUD.  Gold’s work proved that cocaine caused a relative dopamine deficiency, anhedonia & was addicting   Gold pioneered the study of second-hand tobacco, cannabis, and opium smoke. Gold and Kelly Brownell co-chaired the historic Yale Conference on Food and hedonic overeating and the Oxford University Press textbook. Over his 25-year career at the University of Florida, he was a Professor of Neuroscience,  physician-scientist at UF McKnight Brain Institute, and University bench-to-bedside leader. He became a UF Distinguished Professor, Eminent Scholar & Chairman of the Department of Psychiatry.  He was awarded an innovator award from UF President as a translational researcher and inventor for work on Xhale Assurance’s disposable pulse oximetry ala sensor, which Philips acquired in 2018. Dr. Gold was a Founding Director of the MR-guided radiation oncology pioneer Viewray and AxoGen, the nerve recovery and repair platform. Since his retirement, Gold has continued his work as a researcher, mentor, and inventor working at WUSTL. Translating scientific progress to help patients, he worked with ADAPT Pharma on naloxone and naltrexone culminating in a HEAL grant to develop longer-acting formulations. He is on the BOD of education, intervention, and prevention organizations, including CADCA. ASAM presented Gold with the McGovern ” Annual Award for highly meritorious contributions … Lifetime pioneering work”.  Dr. Gold has received the APA’s Foundation Fund Award, APF’s Pillar of Excellence, DEA & NAATP’s Lifetime Achievement Award for Research, and Distinguished Alumni Awards from Yale, WUSTL, and the University of Florida. He was a Founding Editor of the Journal of Addiction Medicine & UpToDate. Currently, the Specialty Chief Editor of SUDs and Behavioral Addictions in Frontiers in Public Health.

Since his retirement as a full-time academic in 2014, Dr. Mark Gold has continued his teaching, mentoring, research, and writing as a University of Florida Emeritus Eminent Scholar, Adjunct Professor in the Department of Psychiatry at Washington University and an active member of the Clinical Council at the Washington University School of Medicine’s Public Health Institute. With Kelly Brownell, he has updated their ground-breaking Food and Addiction by Oxford University Press for a paperback edition and is currently working on updates and revisions for a Second edition. He has analyzed and presented epidemiological research on the opioid and emerging cocaine epidemics. He has written and lectured on responses to reduce overdose deaths, medication assisted therapies and opioid use disorders. He regularly lectures at Medical...

Born and raised in Los Angeles, Richard Taite is the founder and Executive Chairman of Carrara Treatment Wellness & Spa, an “ultra” luxury addiction treatment facility, and the Executive Chairman of 1 Method Centers, affordable substance use disorder treatment facilities. Richard graduated from UCLA with a degree in Political Science and Public Law and intended to become a lawyer, but after struggling with addiction himself, he learned what worked, what didn’t work, and where programs fell short and failed clients. In 2005 he founded Cliffside Malibu, a boutique rehab with only six beds which Richard steadily grew to 83 beds. In June of 2018, Richard sold Cliffside Malibu and took a much-needed break. Due to the exploding fentanyl epidemic, Richard came back to work to help combat this growing issue, and thus Carrara was born. One of Richard’s core beliefs is there is nothing to get, there is only to give. Building this legacy of giving people the life they were always meant to live, and leaving this world better than he found it he believes his children will be proud of. As he always says, a good father only cares about two things, that his children are proud of him, and that they are okay in the world when he is gone.

As a celebrated entrepreneur and visionary leader in the world of addiction treatment during the ever-burgeoning opioid crisis, Richard was a constant presence on television, radio and in magazine articles throughout his tenure at Cliffside, including featured appearances on HBO’s Real Time with Bill Maher, ABC News’ Nightline, CBS’ This Morning, Entertainment Tonight and was the addiction expert in Prescription Thugs, an award-winning documentary, among many others.

What is hemp? The congressional definition is anything less than 0.3% dry weight delta-9 THC. This presents a major loop hole, legalizing intoxicating products that are tested for the first time, not on lab rats, but on our children. Dr. Rossheim is an expert on these derived intoxicating cannabis products and shares his research.

Matthew Rossheim, PhD, MPH, CPH, FAAHB is an Associate Professor in the College of Public Health at the University of North Texas Health Science Center. His work focuses on the marketing of especially high-risk products often used by young people, and he is one of the nation’s leading public health experts on derived intoxicating cannabis products (such as delta-8 THC) and “supersized” alcopops (such as Four Loko). His work, including more than 100 peer-reviewed research manuscripts and scientific presentations, has helped influence the development of laws and regulations from the local- to federal-levels. His research has been cited in reports by the U.S. Food and Drug Administration (FDA) and World Health Organization (WHO), as well as featured by BBC, CNN, CBS, NBC, NPR, Washington Post, and The New York Times. In recognition of his efforts that have profoundly influenced public health policy, he was awarded the 2025 Advocate of the Year award by CADCA.

Teun Voeten (www.teunvoeten.com ) is author of The Devil's Drug.  https://rowman.com/ISBN/9781538198612/The-Devil's-Drug-The-Global-Emergence-of-Crystal-Meth

We discuss his new book. We also look at his photography work cover war, homeless and drugs - his captures the similarity in human suffering.

Teun Voeten studied cultural anthropology and philosophy at Leiden university. As a photographer he has been covering conflicts worldwide since 1991. Voeten wrote books on the underground homeless in New York, the civil war in Sierra Leone and wrote a PhD thesis on the drug violence in Mexico. For the city of Antwerp, he researched drug related crime. Early 2025, The Devil’s Drug: The Global Emergence of Crystal Meth will appear. Currently, Voeten is researching the fentanyl crisis on the West Coast of America, from Tijuana to Vancouver.

Cindy Cipriani, Executive Assistant U.S. Attorney in the Southern District of California, develops partnerships and programs to enhance crime prevention and community resilience. She serves on the Executive Leadership Committee and Co-Chairs the Prevention and Education Committee of San Diego’s Substance Use and Overdose Prevention Task Force, a multi-disciplinary coalition that works across sectors to raise awareness and prevent fatal overdoses, and chairs the Project Safe Neighborhoods Task Force, which funds community groups that facilitate reentry and prevent gangs and gun crime. Ms. Cipriani was a driving force behind San Diego’s Juvenile Smuggling Prevention team, which was recognized by the Attorney General in 2019 as DOJ’s Outstanding Community Partnership for Public Safety. In addition, she has organized numerous events and efforts to protect houses of worship and address targeted violence and hate incidents, earning ADL’s Sherwood Prize for community engagement work combatting hate.  

Ms. Cipriani obtained a Bachelor of Arts in Journalism at The Ohio State University and held staff positions in the Ohio Legislature and the U.S. House of Representatives.  She received her law degree from Georgetown University Law Center and litigated for nearly a decade at Gray Cary Ware & Freidenrich (now DLA Piper) before becoming an Assistant United States Attorney in 1999.  Ms. Cipriani has held several senior management positions, including Deputy Chief of the Civil Division, Executive Assistant U.S. Attorney, First Assistant U.S. Attorney, and Senior Management Counsel.

Soccer Team Video:

Our website has info on Project LEAD and the Juvenile Smuggling Program:

We also have information on United Against Hate. The updated calendar should appear on the website soon!

Drugs are smuggled into the US by land and sea and from Southern as well as Norther Border. Sheriff Milstead discusses the Northern Border.

Mike Milstead began his law enforcement career in 1973 with the Sioux Falls Police Department (SFPD).  He served over 24 years on the SFPD, with assignments in all Divisions of that department, rising to the rank of Lieutenant detailed as the Night Shift Commander.  

In 1997, Mike Milstead was sworn in as Sheriff of Minnehaha County.  He has served as Sheriff for over 27 years.  Sheriff Milstead is on the Board of Directors of the National Sheriff’s Association (NSA) and is the Chair of the NSA Drug Enforcement Committee.  He served on the DHS Homeland Security Information Network Advisory Committee (HSIN-AC) and is currently a member of the DHS S&T First Responders Resource Group (FRRG).  Sheriff Milstead is the Chair of the Department of Justice Global Advisory Committee (GAC) and also represents NSA and GAC on the Criminal Intelligence Coordinating Council (CICC).  For the past 25 years, he has served on the Executive Board of Mid-West HIDTA, the FBI Joint Terrorism Task Force and the Governor’s Senior Advisory Committee for Homeland Security.  He also represents South Dakota Sheriffs on the SD Fusion Center Advisory Board.  

The Minnehaha County Sheriffs Office is a full service law enforcement, public safety and corrections agency that serves the 200,000 people who live in the most populated county in South Dakota. With over 250 full and part-time employees, the Sheriff's Office is responsible for the preservation of peace and the protection of life and property within the jurisdiction. 

The Impact of Schizophrenia Genetic Load and Heavy Cannabis Use on the Risk of Psychotic Disorder in the EU-GEI case control and UK Biobank studies.  This article published in Psychology Magazine Apri 2024 studied 114,698 European patients to determine if genetics was associated with cannabis associated psychotic disorder. Regular users of high potency THC (over 10%) had the highest odds of psychotic disorder independent of schizophrenia genetics. Dr. Marta DiForte explains this research.

Dr Marta Di Forti is a Clinical Reader in Psychosis Research at the Dept of Social, Developmental and Genetic Research, Institute of Psychiatry, and Honorary Consultant Adult Psychiatrist, Lambeth EI Community team, South London and Maudsley NHS foundation Trust. She leads the first Cannabis Clinic for patients with Psychotic disorders in UK. She was recently awarded the Royal College of Psychiatrist Researcher of the year prize.  In 2020 she was granted a MRC Senior Research Fellowship to expand her research in the role of cannabis use in psychosis and its underlying biology. With her team she showed for the first time that use of high potency types of cannabis e.g. "skunk" carries a higher risk of psychosis than use of traditional types and that it affects rates of Psychotic disorders across Europe. Though it still remains unclear who are those cannabis use most at risk. Her future work aims to investigate the interaction between cannabis use and genes predisposing to schizophrenia, and how cannabis changes the epigenome.

Dr. Matthew Fedoruk currently works as the Chief Science Officer leading the Science & Research team at the U.S. Anti-Doping Agency (USADA). Dr. Fedoruk is considered an expert in the scientific aspects of anti-doping matters and has reviewed hundreds of results management cases while at USADA and provided credible scientific guidance and opinion to resolve many anti-doping analytical and non-analytical result management cases including the detection of performance-enhancing drugs and the abuse thereof in sport. With more than 10 years of experience in anti-doping and a Ph.D. in Pathology and Laboratory Medicine, Dr. Fedoruk also serves as a standing member of the IPC Anti-Doping Committee, the WADA TDSSA Expert Group Chair and Athlete Biological Passport (ABP) Ad-Hoc Working Group. Dr. Fedoruk also serves as co-Chair of the Scientific Advisory Board for the Partnership for Clean Competition (PCC). Before joining USADA, Dr. Fedoruk worked at the Canadian Centre for Ethics in Sport (CCES) and served with the Vancouver 2010 Organizing Committee for the 2010 Olympic and Paralympic Winter Games in Canada. He currently lives in sunny Colorado Springs, Colorado, which is also known as ‘Olympic Town USA’ for being home to the U.S. Olympic Committee, the high-altitude Olympic Training Center, numerous national sport federations and USADA.

Allison Wagner

The U.S. Anti-Doping Agency (USADA) is pleased to announce that it has welcomed Allison Wagner, a silver medalist swimmer at the 1996 Olympic Games in Atlanta, as its first Director of Athlete and International Relations.

In this role, Wagner will oversee Olympic, Paralympic, Pan American, and Parapan American athlete engagement efforts that will help USADA serve athletes and best meet their needs. Wagner will also work to ensure effective relationships with key international partners and advocate for anti-doping excellence on a global scale.

In addition to her experience as an elite swimmer, Allison brings to this role her recent experience as a research associate at the Sports Equity Lab at Yale University and as a postgraduate student in the Erasmus Mundus Program, a joint master’s degree delivered by an international consortium of six higher education institutions in the European Union.

Wagner is one of six Olympians worldwide to be selected by the International Olympic Committee for this program – a world-first innovation developed by the European Commission as a response to the global challenge to sport integrity. These programs allowed her to lead athlete outreach initiatives and develop expertise in international relations and sport governance, anti-doping policy, abuse and discrimination, athletes’ rights and advocacy, diversity and inclusion, and disability in sport. With this knowledge, she developed concrete and practical solutions related to policy, governance, and communication.

“Allison is passionate about athletes’ rights and standing up for them,” said USADA CEO Travis T. Tygart. “As an Olympian and scholar, through engagement with our athletes and international partners, Allison will elevate our mission to serve athletes and ensure that their rights are protected around the world.”

Wagner also has first-hand experience with one of the key reasons that a strong global anti-doping system is so important: She was beaten in major championships by swimmers who were later proven to be users of banned performance-enhancing substances. Despite these challenges, Wagner enjoyed a decorated swimming career, including holding a world record in the 200 I.M. (SCM) for almost 15 years, seven Southeastern Conference titles, 11 All-American honors, recognition as the SEC Female Swimmer of the Year in 1995 and 1996, and the University of Florida’s Most Valuable Swimmer in 1996. She earned the silver medal in the 400-meter...

Dr. Lora Peppard is the Executive Director of the Center for Advancing Prevention Excellence at the University of Baltimore and the Director of ADAPT, a national training and technical assistance division for substance use prevention for the High Intensity Drug Trafficking Area Program out of the Office of National Drug Control Policy. She also serves as the Immediate Past President of the American Psychiatric Nurses Association and sits on the Board of Directors for Columbia University’s Nursing Alumnae Association and the Advisory Board for SAMHSA’s Prevention Technology and Transfer Center’s Network Coordinating Office. Dr. Peppard has over 21 years of clinical experience as a psychiatric nurse practitioner serving a variety of populations including adolescents and young adults. She has led multiple federally funded grants and developed system-wide strategies to address the unique substance use and behavioral health needs in communities across the nation. Dr. Peppard has authored several publications and serves as a community, state, national, and international consultant on prevention.  

School based prevention education is one of the pillars to tackling the drug crisis along with treatment and supply. LEAD is a key partner in this effort.

Nick DeMauro is the Executive Director of Law Enforcement Against Drugs and Violence (L.E.A.D.) 

Under Nick’s leadership, L.E.A.D. has grown to be the country’s leading organization teaching first responders and community leaders how to effectively teach anti-drug and anti-bullying to students.   

After earning a degree in Human Services, he joined the New Milford NJ police force, becoming the youngest detective in the agency’s history and launching its juvenile division being awarded two Police Officer of the Year Awards  Sensing the importance of the issue of substance abuse among youth, Mr. DeMauro’s  career path led to his appointment as in international executive in  a drug prevention program (DARE). In New Jersey, over 17 years, he built the largest law enforcement school based statewide charitable organization in the United States. His commitment to positive student outcomes fostered a dedicated vision and goal for law enforcement agencies to provide evidence based, proven effective curricula in the context of comprehensive programming.  In 2015, he was appointed Executive Director and CEO of L.E.A.D. (Law Enforcement Against Drugs and Violence), A New Jersey based national nonprofit organization designed to facilitate all law enforcement drug and violence prevention efforts throughout the United States and beyond.  Recipient of many leadership awards, his passion includes promoting community-based law enforcement efforts to assist communities foster a safe and healthy environment. Mr. DeMauro’s recent appointment to the Board of Directors of Applied Prevention Science International, Inc. is a prime example of his commitment to good prevention science, superior policy and realistic implementation of evidence-based programming.  Mr. DeMauro and his family reside in Belmar NJ and Naples Fla.

Each Saturday beginning at Noon, L.E.A.D. guy Nick DeMauro, speaks with experts, educators and law enforcement about important issues affecting you and your children. Tune into AM 970 The Answer for topical information and insight from experts waging the battle against drugs and violence in your community.  

What are the effects of cannabis on the cardiovascular system? Dr. Chandy helps clear the haze. The American Heart Association has established the facts.

Dr. Mark Chandy earned his MD and Ph.D. in 2008, at Pennsylvania State University. After completing

medical school, Dr. Chandy trained in Internal Medicine at the University of British Columbia, followed

by a Cardiology fellowship at the University of Toronto. He also completed a fellowship in

Echocardiography and enrolled in the Clinician Scientist Training Program at the University of Toronto.

With a desire to learn stem cell biology, Dr. Chandy trained in induced pluripotent stem cells (iPSCs)

disease modeling at Stanford University. Dr. Chandy’s research has been published in Cell and other

high-impact journals. He holds patents for his novel discoveries. As a recently appointed Assistant

Professor at the University of Western Ontario, Dr. Chandy is an independent physician-scientist using

iPSC disease modeling, next-generation sequencing (NGS), proteomics, and gene editing to

understand the mechanisms of cardiovascular disease. Dr. Chandy's current research focuses on

understanding the pathophysiology of environmental exposures such as air pollution, e-cigarettes, and

cannabis on cardiovascular disease using human iPSC-derived tissue. The overarching goal of his

research is to 1) investigate the effects of the environment on the cardiovascular system, 2) discover

biomarkers to risk stratify patients, and 3) discover druggable target genes for cardiovascular disease.

The relationship between cannabis and cardiovascular disease: clearing the haze. Nature Reviews. Jan 2025

What does the textile industry and families against fentanyl have in common? They both want to eliminate the De Minimus Loophole that allow foreign goods under $800 to pass into the United States with little scrutiny or taxes. It is one way fentanyl is entering the US.

Kim Glas joined the National Council of Textile Organizations (NCTO) in May 2019 as President and CEO. NCTO represents the broad spectrum of the domestic textile industry from fiber to finished products. She has over 20 years of experience in government policy development and advocacy. Kim also serves as an appointed Commissioner to the US-China Economic and Security Review Commission. 

Her multi-faceted career includes spearheading manufacturing and trade policy efforts on Capitol Hill, serving as a key leader on behalf of the textile industry, and previously leading a non-profit organization, BlueGreen Alliance, engaged in advancing critical policies to grow quality, U.S. jobs in the clean energy economy.

Kim served as the Deputy Assistant Secretary for Textiles, Consumer Goods, and Materials at the U.S. Department of Commerce. In that role, she worked to improve the domestic and international competitiveness of the broad product range of U.S. industries. She also served as the chairman for the Committee for the Implementation of Textile Agreements.

Read about the Close the De Minimis Coalition

Read about How fentanyl traffickers are exploiting a US trade law to kill Americans

Jan Rader is a star of the Netflix special Heroin(e) and hero in West Virginia in the drug epidemic.

Native of Ironton, Ohio, Jan Rader joined the Huntington Fire Department in August of 1994. Ms. Rader is the first woman to reach the rank of Chief for a career department in the State of West Virginia. She holds a Regents Bachelor of Arts degree from Marshall University and an Associates Degree of Science in Nursing from Ohio University. Jan holds many fire service certifications and is also a Fire and EMS Instructor in the State of West Virginia. Chief Rader came to national prominence after the release of the short documentary “Heroin(e)” by Netflix in September of 2017. Then in April of 2018, she was chosen as one of Time Magazine’s list of the 100 most influential people in the world. She retired from the City of Huntington Fire Department in February of 2022 and currently serves as the Director of the Mayor’s Council of Public Health & Drug Control Policy. The purpose of this council is to address substance use disorder in Huntington and the surrounding communities and to create a holistic approach involving prevention, treatment, recovery, and law enforcement. 

Alcohol prohibition. Taxes. Quality standards. Potency regulation. What can healthcare policy learn from alcohol and tobacco and apply to today's cannabis market?

David Jernigan, PhD, is a Professor of Health Law, Policy and Management at the Boston University School of Public Health, and senior policy advisor for CityHealth, a project of the de Beaumont Foundation that provides leaders with a package of evidence-based policy solutions that will help millions of people live longer, better lives in vibrant, prosperous communities.

Dr. Jernigan is best known for his action-research approach to the issue of alcohol advertising, marketing, and promotion and its influence on young people. His work has led to better advertising regulations and a clearer understanding of the evolving structure of the alcohol industry. His work is policy relevant and scientifically rigorous. Dr. Jernigan has been very active in translating research findings into policy and practice. He testifies regularly at city, state, and national levels around alcohol advertising and youth, alcohol availability, and taxation. He also trains advocates around the world using the best evidence.

Cannabis: Moving Forward, Protecting Health

Disease burden is the impact of a health problem as measured by financial cost, mortality, morbidity or other indicators. When it comes to drugs, we are always talking about overdoses and deaths.  The CDC predicted deaths in the US for the 12 months preceding March 2024, are over 103,000. That is horrible and unacceptable. Death is just the tip of the iceberg. For every death there are many more with a substance use disorder, as well as a host of medical and mental health conditions associated with drugs. 

There are proponents of judging drugs like we do other health problems like injuries or cardiovascular disease. That is looking at the total disease burden, not just deaths.

For example, disability for depression and back pain rated much higher in disease burden compared to diabetes, emphysema and asthma combined. Yet we know emphysema is more lethal than back pain.  In this episode we will discuss the disease burden of drugs and alcohol.

Vaughan Rees, pHD

Dr. Rees is Director of the Center for Global Tobacco Control, whose mission is to reduce the global burden of tobacco-related death and disease through training, research, and the translation of science into public health policies and programs. He directs the Tobacco Research Laboratory at the Harvard Chan School, where the design and potential for dependence of tobacco products are assessed. Studies examine the impact of dependence potential on product use and individual risk, to inform policy and other interventions to control tobacco harms. Current research uses conventional and innovative strategies to evaluate new and novel tobacco products. Examples of these products include modified risk tobacco products such as e-cigarettes; reduced ignition propensity cigarettes; hookah (tobacco waterpipe); and novel smokeless tobacco products such as snus. Clinical research methods are used to evaluate the influence of tobacco product design features on consumer responses, and their role in promoting initiation or maintenance of use among targeted populations. Findings have been used to inform tobacco control policy, develop resources for communicating risks of tobacco products, and to enhance understanding of factors that contribute to tobacco dependence.

Other research involves development of strategies to reduce secondhand smoke (SHS) exposure in domestic environments, with a focus on evaluating interventions for reducing domestic SHS exposure among children. Dr. Rees also leads an NIH funded study which seeks to reduce secondhand smoke exposure among children from low income and racially/ethnically diverse backgrounds. This research utilizes the principles of community based participatory research (CBPR) to develop and evaluate a cognitive behavioral intervention to help caregivers maintain a smoke free home environment. He has conducted studies on SHS emissions of tobacco waterpipe, and SHS monitoring in indoor environments, including private homes and cars.

Dr. Rees' academic background is in health psychology (substance use and dependence), and he trained at the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, Australia, and did postdoctoral training through the National Institute on Drug Abuse. He has also published research on the role of cue reactivity in tobacco and alcohol abuse and dependence; and clinical trials on interventions for alcohol and cannabis dependence.

Towards a Comprehensive Measure of Drug Attributable Harm, JAMA

Connor Kubeisy

Connor Kubeisy is a Policy Analyst with the Foundation for Drug Policy Solutions and its sister organization, Smart Approaches to Marijuana, after having joined them as a Communications and Policy Associate in January 2022. He began his career as an intern in the White House Office of National Dru...

Dr. Nora D. Volkow, M.D., is the longest residing Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health since 2003.

She is the world's go to person when it comes to the issue of drugs, and commonly known as the mother to the science demonstrating that drug addiction is a brain disorder. 

Dr. Volkow continues her tradition of starting the High Truths podcast season with reflections and hopes in the issue of drugs.

Hello and Welcome to Season 5 of  High Truths on Drugs and Addiction. What an honor and joy I have from hosting High Truths.  Each episode I have great discussions with fascinating and knowledge people who get me thinking and teach me something new. It is like the Talmudic saying in Ethics of our Fathers, Who is Wise, One who learns from every person. And you and I learn so much from our High Truths guest. Talmudically speaking - I guess that means we are all wise.

Can you believe that we already had 210 conversations with fascinating people? I love it. But more importantly, the conversations we have - lead to action, drug policies and solutions. 

Talk is great, but as the saying goes, Action speaks louder than words. Keeping with our High Truths tradition, this first episode of Season 5 will be just me sharing with you my monologue for the year.This is the one and only time of year where you hear just from me, and the rest of the season is dialogue with my guests. Here is what I want to cover with you today.

• First Reflections about this High Truths Podcast
• Then a state of the union on the drug data.
• And ending with hopes for our future with solutions and action.

So here I go...

The High Truths Season Finale airs the live conversation from December 13 with Drs. Bertha Madras, Libby Stuyt and Aaron Weiner. The experts share their reflections on 2024, hopes for 2025, and advice for the new Trump administration.

Cannabis Use Disorder and Cannabis Induced Psychosis is a common diagnosis of adolescent psychiatrist. Listen to Dr. David Rettew's tips in diagnosis and how to speak to young people about marijuana.

David Rettew, MD is a child & adolescent psychiatrist who currently works as the Medical Director of Lane County Behavioral Health in Eugene, Oregon.  He is also a clinical faculty member in the Psychiatry Department at OHSU.  Before moving to Oregon in 2021, he worked as a tenured associate professor of psychiatry and pediatrics at the University of Vermont Medical Center and was Medical Director of the child and families division of the Vermont Department of Mental Health.  He was also past president of the Vermont Association of Child and Adolescent Psychiatry.  Dr Rettew built and then acted as first Training Director of UVM’s child psychiatry fellowship program.  He is the author of over 60 peer reviewed journal articles on a variety of mental health topics as well as two books, including Parenting Made Complicated: What Science Really Knows About the Greatest Debates of Early Childhood. He has served as the co-chair of the American Academy of Child & Adolescent Psychiatry’s (AACAP) Health Promotion and Prevention committee and was previously on their journal’s (JAACAP’s) editorial board.  Dr. Rettew did his general psychiatry and child & adolescent training at Harvard Medical School within the combined Massachusetts General/McLean Hospital programs.  Dr. Rettew writes a regular blog on Psychology Today that has over one and a half million views. 

The United States's Drug Czar is in charge the nation's drug policy. We can learn from the historical perspectives of our prior leaders. Gil Kerlikowske shared his insights.

I served as the Commissioner of U.S. Customs and Border Protection (CBP), having been nominated by President Obama and confirmed by the Senate in March, 2014.  Having left office in January 2017, I will be the only confirmed CBP Commissioner during President Obama’s administration.

CBP was formed as part of the Department of Homeland Security in 2003 as a result of the recommendations issued by the 9/11 Commission. Its dual responsibilities are to secure America’s borders and facilitate lawful travel and trade. CBP is the second-largest contributor of funds to the U.S. Treasury, collecting $46 billion in Fiscal Year 2015. As the nation’s largest law enforcement agency, CBP employs 60,000 people at and between 328 ports of entry nationwide as well as in 40 countries around the world, with an annual budget approaching $13 billion.

One of my chief accomplishments at CBP was realigning an organization that had 21 direct reports to the Commissioner. The new organization streamlines decision-making and gives CBP’s workforce more efficient access to resources and information. I also oversaw the restructuring of the U.S. Border Patrol (which comprises 21,000 personnel), including the appointment of the first Border Patrol Chief from outside the organization since its founding in 1924. Under my leadership, CBP has made significant changes its use of force policies, incorporating new training at its academies and implementing robust internal affairs review and investigation authorities, which CBP did not have previously.

In addition, during my tenure CBP has expanded the use of technology to make it faster and easier for lawful travelers and cargo to enter the country securely – contributing to both national and economic security. Regarding travel, I oversaw the expansion of CBP’s Preclearance facilities overseas, placing Customs officers in key foreign cities to pre-inspect travelers destined to the United States, thereby adding a layer of security to our borders while facilitating the arrival of travelers from these cities. Regarding trade, I oversaw the enforcement of laws prohibiting goods derived from forced or child labor, counterfeit goods, or products that violate trade agreements and could harm the U.S. economy or consumers. 

CBP also has an important global presence; I lead the U.S. delegation to the 180-member World Customs Organization and I travel extensively internationally.  As a veteran of the United States Army – having served in the Army’s military police from 1970-1972 – I oversaw the creation of CBP’s National Frontline Recruitment Center which is designed to attract and recruit military veterans.

Before I was named CBP Commissioner, I served for five years as President Obama’s drug policy advisor as Director of the Office of National Drug Control Policy (ONDCP), a Senate-confirmed cabinet level position. When I started at ONDCP in May 2009, the growing abuse of and addiction to prescription drugs was not widely known by the general public. Besides authoring the ONDCP’s annual National Drug Control Strategy, I initiated the first Prescription Drug Strategy. 

During my tenure at ONDCP, law enforcement began using Naloxone to save victims of opiate overdoses. In addition, hospitals began changing their emergency department standards on pain medication, and physicians and dentists began receiving better guidance on the problem of prescription drug abuse and addiction. Non-governmental organizations and advocacy groups were welcomed into the drug policy conversation, which expanded from purely a law enforcement-centric discussion to include the necessary focus on public health. I received the Nathan Davis public service award from the American Medical Association, and I als...

Ben traveled to China to buy some fentanyl precursors. What he learned shapes health policy to this day. Now he is banned from China travel.

Ben Westhoff is an award-winning investigative reporter whose books are taught around the country and have been translated around the world, including Fentanyl, Inc.: How Rogue Chemists Created the Deadliest Wave of the Opioid Epidemic, the bombshell first book about the fentanyl epidemic. He has advised officials at the top levels of government about the opioid crisis, writes the Substack newsletter Drugs + Hip-Hop, and is currently directing a film about the opioid treatment drug naltrexone, called Antagonist. His book Original Gangstas: Tupac Shakur, Dr. Dre, Eazy-E, Ice Cube and the Birth of West Coast Rap is the definitive book about West Coast Hip-Hop. He has written for The New York Times, The Atlantic, The Wall Street Journal, Rolling Stone, and the Guardian, and been interviewed as an expert commentator on CNN, NPR, and CSPAN, and on full, dedicated episodes of Fresh Air and the Joe Rogan Experience. 

Once upon a time, a long time ago, in 1990, people were dying of prescription opioids. Those were the 'good ol days" when 100 people a day were dying from drugs. Today we are at 300 a day. There is much to learn from history and my conversation with Mary Bono.

The Honorable Mary Bono is a successful businesswoman and well-known political leader, Congresswoman Mary Bono was hailed as the "embodiment of powerful American womanhood" by the Washington Times during her tenure in the United States House of Representatives. Mary was elected to Congress in 1998 to serve California's 44th (later changed to 45th) Congressional District after the untimely death of her husband, entertainer turned Congressman Sonny Bono. She established herself as a respected and closely- watched leader on a wide range of critically important issues while serving 7 terms in Congress (1998-2013). She served on the Energy and Commerce, Armed Services, Judiciary, and Small Business Committees. A proven bipartisan consensus builder, Mary authored legislation that was signed into law by three Presidents: Clinton, GW Bush and Obama. Today, Mary is widely recognized as a national leader on multiple issues, including addiction prevention, treatment, and recovery. While serving in Congress, she co-created the first ever Prescription Drug Abuse Caucus and chaired hearings specific to the opioid abuse epidemic. She continues to be at the forefront of the nationwide fight against drug abuse and the fentanyl epidemic, both of which impact every community in the country. She currently serves as the Chair of the Board of Mothers Against Prescription Drug Abuse (MAPDA). In 2022, Mary received Distinguished Graduate Merit Award from her alma mater, the University of Southern California. She is married to former astronaut and Rear Admiral Steve Oswald (U.S. Navy, Retired) and is mother, a grandmother, and a dog mom. 

Drug hijack your dopamine. Dopamine is a neurochemical we need to live. We need it like oxygen and water. Without it, people feel they are dying.

Anna Lembke, MD is professor of psychiatry at Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. A clinician scholar, she is the author of more than a hundred peer-reviewed publications, has testified before the United States House of Representatives and Senate, has served as an expert witness in federal and state opioid litigation, and is an internationally recognized leader in addiction medicine treatment and education.

In 2016, she published Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop (Johns Hopkins University Press, 2016), highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018). 

Dr. Lembke appeared in the Netflix documentary The Social Dilemma, an unvarnished look at the impact of social media on our lives. 

Her latest book, Dopamine Nation: Finding Balance in the Age of Indulgence (Dutton/Penguin Random House, August 2021) was an instant New York Times and Los Angeles Times bestseller and has been translated into 35 languages. It combines the neuroscience of addiction with the wisdom of recovery to explore the problem of compulsive overconsumption in a dopamine-overloaded world.

Dawn, a prevention specialist noticed brightly colored packing of mushroom products in a smoke shop near a school. She wanted to know what they were selling children. Dawn found Josh Swider who agreed to testing of several products. The results were shocking - the products included a range of chemicals from THC to bath salts. Consumer protections are important for food and all types of drugs, especially when sold legally.

Josh began his career in chemistry at Eastern Washington University, where he earned his Bachelor of Science in Chemistry and degrees in physics and biology. His quest for a deeper understanding of science led him to graduate school, where he attended the joint doctoral program at the University of California, San Diego, and San Diego State University. Josh saw the problems in the analytical cannabis industry with the lack of analytical research and public understanding associated with it. He wanted to change this, and with his knowledge and passion for the industry, Josh founded the lab with fellow chemist Dave Marelius in 2016. Together they’ve made it InfiniteCAL’s mission to ensure only safe; quality products are allowed to be sold to consumers

Connor Sheets' investigative stories have resulted in public health alerts, federal investigations, and international ramifications. His investigations included finding that Mexican pharmacies were selling counterfeit pain pills that contain fentanyl and smoke shops were selling chocolate magic mushrooms that contain THC or bath salts.

Connor Sheets is an investigative and enterprise reporter for the Los Angeles Times. He was part of the team that was a 2024 Pulitzer finalist for its coverage of the mass shooting in Monterey Park. Before joining The Times in 2021, he worked for six years as an investigative reporter in Alabama, reported from four continents as a New York-based enterprise reporter and covered local news for a weekly newspaper chain in Queens. A father of two, Sheets grew up in Maryland, where he delivered newspapers as a teenager and landed his first reporting job after graduating from the University of Maryland.

Social media handle: https://x.com/ConnorASheets

56% of drivers involved in serious injury and fatal crashes tested positive for a least one drug.  I talked to Ari Briskman to get boots on the ground law enforcement perspective of drugged driving.

Sergeant Ari Briskman has served as a law enforcement officer since 2007. Ari is presently assigned full-time as the Commander of the Marine Unit for the Lake County Sheriff’s Office. Ari also serves the Sheriff’s Office as the Technical Crash Investigation Team Commander, the Auxiliary Deputy Unit Commander, and as a Public Information Officer.

Ari has dedicated much of his career to impaired driving enforcement and traffic safety. He is a certified Drug Recognition Expert, certified Drug Recognition Expert – Instructor, Standardized Field Sobriety Test Instructor, Seated Standardized Field Sobriety Test Instructor, and certified Crash Reconstruction Specialist. Ari has been recognized by courts in several counties in northern Illinois as an expert in the fields of alcohol and drug impairment. 

Ari has personally apprehended over 600 impaired vehicle and boat operators throughout his career, for which he has been recognized several times by Alliance Against Intoxicated Motorists and Mothers Against Drunk Driving. He has consulted with and assisted in the prosecution of hundreds of additional impaired driving cases throughout Illinois.

Ari has been contracted with various Illinois training units as an instructor to teach all the National Highway Traffic Safety Administration impaired driving enforcement courses, the National Association of State Boating Law Administrators boating under the influence courses, and his own original material. Ari serves as an adjunct instructor for the Homeland Security Training Institute at the College of DuPage teaching course material on drug impairment in the workplace. Ari is also a senior consultant for Dynamic Impairment, LLC, for whom he provides consultancy services to private businesses and court litigants on drug policies and impairment recognition. 

In addition to his law enforcement duties, Ari advocates for stronger impaired driving laws and protections for crash victims as a member of the Board of Directors of the Alliance Against Intoxicated Motorists. Ari also serves as a board member for the State of Illinois Impaired Driving Task Force and on the speaker’s bureau for the National Marijuana Initiative.

Ari holds a Bachelor of Science degree in Law Enforcement and Justice Administration and a Master of Arts degree in Public Safety Administration, both from Western Illinois University.

Drug and Alcohol Policy dates to Talmudic times. Ancient Rabbis established rules, or policy for their village. They told their people to avoid crossing to the neighboring village on the Sabbath because those neighbors had a reputation for excessing drinking.

Today drug policy can be extremely liberal - allowing free drug trade with no consequences, or very harsh - the death penalty for drug dealing. Smart drug policy strikes the right balance.

Paul J. Larkin is the John, Barbara, and Victoria Rumpel Senior Legal Research Fellow in the Meese Center for Legal and Judicial Studies. Larkin works on criminal justice policy, drug policy, and regulatory policy. Before joining Heritage in September 2011, Larkin held various positions with the federal government in Washington, D.C. At the U.S. Department of Justice from 1984 to 1993, Paul served as an Assistant to the Solicitor General and argued 27 cases before the U.S. Supreme Court. He also was an attorney in the Criminal Division’s Organized Crime and Racketeering Section. In 1996-1997, Larkin served as Counsel to the Senate Judiciary Committee and head of the Crime Unit for Sen. Orrin Hatch (R-Utah), then the panel’s chairman. He worked in the Environmental Protection Agency from 1998 to 2004 as a special agent for criminal enforcement, eventually becoming Special Agent-in-Charge and serving as Acting Director of the EPA Criminal Investigation Division in 2004. His honors include the Secretary of Defense Medal for Meritorious Civilian Service, which he received in 1994 for representing the military before the Supreme Court. In the private sector, he worked at two top law firms in Washington, D.C., and as Assistant General Counsel for Verizon Communications from 2004 to 2009. Larkin received his law degree in 1980 from Stanford Law School, where he was a published member of the Stanford Law Review. He clerked for Judge Robert H. Bork of the U.S. Court of Appeals for the D.C. Circuit. In 2010, he received a master’s degree in Public Policy from George Washington University. He also holds a bachelor of arts degree in Philosophy from Washington and Lee University in Lexington, Virginia, where he graduated summa cum laude with honors in Philosophy. Born and raised in New York, New York, Larkin is a life-long New York Yankees and New York Giants fan.

Fentanyl is the public health crisis of our times with 300 deaths a day from drugs, 60% driven by fentanyl. It is a humanitarian crisis. Fentanyl is a weapon of mass destruction. Quick fentanyl detection is important, and nanotechnology is playing a big role.

Dr. Shalini Prasad’s research focuses on designing miniature cellular and molecular platforms, with the goal of creating faster and more affordable clinical diagnostics.

She is currently a Cecil H. and Ida Green Professor in Systems Biology and a professor in the Department of Bioengineering. She also holds an adjunct appointment as professor in the Department of Physics at Portland State University.

Prasad is the director of the Biomedical Microdevices and Nanotechnology Lab, which has supported 22 graduate researchers and 30 undergraduate researchers over the last eight years. Her multi-disciplinary work includes the engineering of multi-functional nanomaterials for designing portable devices and platforms for cellular and molecular diagnostics. Her research improves devices for faster, more affordable and accurate diagnosis of cancer, neurodegenerative diseases, and cardiovascular diseases.

Prasad earned her doctoral degree in electrical engineering in 2004 from the University of California, Riverside. Her multidisciplinary research work won her the graduate student research award in 2004. From 2005 to 2008, she worked as an assistant professor in the Department of Electrical and Computer Engineering at Portland State University and an adjunct assistant professor in the Department of Biomedical Engineering at Oregon Health Sciences University.

From 2008 to 2010, she worked as a research assistant professor and a content expert in the area of organic/inorganic interfaces for the Arizona State University node of the National Nanotechnology Infrastructure Network and ASU’s Center for Solid State Electronics Research. From 2010 to 2011, she was an associate professor at Wichita State University in the Department of Electrical Engineering and Computer Science and the Bomhoff Distinguished Professor of Bioengineering.

Prasad’s research work has been supported by a number of federal and state agencies as well as corporate entities. She has more than 30 peer-reviewed journal publications and is the recipient of a number of awards in the area of nano-biotechnology.

College is a special time in a young person's life. It is a time of personal growth and learning. It is often the first time to live alone away from home. Freedom. Yet colleges pride themselves as being a top party school, like a badge of honor. Responsibility. While on spring break, 22 year old Riley Strain died because of such partying. His alcohol level was 0.228% and his THC level was over 50mg/ml, higher than the machines even test for. May his memory be a blessing for his family. May no other college students have such party experiences.

Rich Lucey has more than three decades of experience at the state and federal government levels working to prevent alcohol and drug use and misuse among youth and young adults, especially college students. He currently serves as a senior prevention program manager in the Drug Enforcement Administration’s Community Outreach and Prevention Support Section. Rich plans and executes educational and public information programs, evaluates program goals and outcomes, and serves as an advisor to the Section Chief and other DEA officials on drug misuse prevention and education programs. Rich formerly served as special assistant to the director for the federal Center for Substance Abuse Prevention, and worked as an education program specialist in the U.S. Department of Education's Office of Safe and Drug-Free Schools.

Erin Ficker is an expert in substance misuse prevention, an accomplished training and technical assistance (T/TA) provider and a certified senior prevention specialist. She brings extensive expertise in supporting, designing, and delivering engaging professional learning, and providing comprehensive T/TA for states and community level prevention professionals. For over 18 years, she has built the capacity of clients to perform prevention work effectively using the Strategic Prevention Framework (SPF). She has in-depth knowledge and training experience in the SPF process, including specific work in evaluation, sustainability, assessment, and working with diverse populations.

Erin currently serves as a regional director in SAMHSA’s Strategic Prevention Technical Assistance Center (SPTAC) working to provide training and technical assistance to SAMHSA state and community grantees across HHS Regions 5 and 8. She also serves as a prevention manager for the Great Lakes Prevention Technology Transfer Center (PTTC) providing services to a wide range of prevention and behavioral health specialists.  Erin holds an MPA in Domestic and Social Policy from the University of Texas-Austin and a BA in Sociology from The Evergreen State College. She also holds a certification as a Senior Prevention Specialist through the Illinois Certification Board.

www.DEA.GOV/onepill

CampusDrugPrevention.gov

https://www.campusdrugprevention.gov

They devil is in the details, or lack of details when in comes to Amendment 3, Florida's ballot initiative on legalizing marijuana. When California and other states legalized weed without including regulations and consumer protections, babies were poisoned, people were exposed to pesticides and contaminants, high potency products proliferated, emergency visits for cannabis poisoning skyrocketed, and people experience second hand smoke on a regular basis. We hope Florida learns from the mistakes of California.

Dr. Jessica Spencer set the foundation for her work in the field of substance abuse prevention by earning a Bachelor of Arts degree in criminology from the University of Tampa and working with at risk juvenile and adult populations in the Tampa area.  Spurred on by a desire to contribute more to her field, she subsequently rounded out her education with a master’s degree in substance abuse counseling and education and a doctorate of education in organizational leadership with a focus on substance abuse prevention and treatment. Her dissertation topic was examining strength-based treatment planning with adolescents.

She is a certified prevention and addictions professional with over 24 years in the prevention and treatment field. Dr. Spencer has developed the ability to quickly identify and resolve issues through conventional and unconventional means bringing meaningful growth to agencies, community groups, and coalitions. Over the years, Jessica has served on many mental health and substance abuse prevention community boards.

She served as the face of the Vote No on two campaigns to defeat the proposed constitutional amendments to legalize marijuana for medical purposes during the 2014 and 2016 campaign cycles. She signed on to the No on 3 campaign team this year as director of advocacy to help defeat the amendment because it is a bad plan for Florida.

In a study of 11,363 individuals with no psychotic disorder, cannabis use increased the risk of psychosis by 11 fold for ages 12 – 19.  I spoke with master behind the research.

André McDonald, PhD, MPH, is an epidemiologist and postdoctoral fellow at McMaster University’s Peter Boris Centre for Addictions Research and Michael G. DeGroote Centre for Medicinal Cannabis Research. Dr. McDonald’s research focuses on the intersection between mental health and addictions among youth. Currently, his primary interest is in understanding the link between youth cannabis use and risk of mood, anxiety, and psychotic disorders. Dr. McDonald is supported by a Fellowship from the Canadian Institutes of Health Research (CIHR).

Dr. McDonald completed his PhD in epidemiology and MPH in social and behavioural health sciences at the University of Toronto while working at the Centre for Addiction and Mental Health. Prior to his graduate studies, he worked in Nunavut (Canada’s northernmost territory) on mental health and addictions issues among Inuit. Overall, he has over 10 years of experience working in the field of public health in both research and policy roles.

There is a lot to learn from the history of Big Tobacco, and we can get that history from Professor Richard Daynard, the man who went after Big Tobacco.

Professor Daynard is at the forefront of an international movement to establish the legal responsibility of the tobacco industry for tobacco-induced death, disease and disability. He is president of the law school’s Public Health Advocacy Institute, chairs its Tobacco Products Liability Project and helped initiate its new Center for Public Health Litigation. Recently, he has worked with PHAI on issues involving obesity, gambling, opioids, gun control and e-cigarettes.

Professor Daynard has written or co-authored more than 90 articles. He teaches in the areas of public health law, strategic litigation and interdisciplinary studies, and has lectured about legal issues in the control of tobacco and obesity in 54 countries as well as chaired 25 national and international conferences on these subjects. Professor Daynard is frequently honored, most recently with Northeastern University’s Pioneer Award. In 2019, he received the Robert Morris, Sr. Award for Courage in Litigation from the Massachusetts chapter of the American Board of Trial Advocates (ABOTA).

Professor Daynard has been the principal investigator in grants and contracts from the National Cancer Institute, the Massachusetts Department of Public Health, the American Legacy Foundation and the Robert Wood Johnson Foundation. Professor Daynard’s academic interests currently center of the intersections among law, public policy and the behavioral sciences, and he teaches courses in the field both to law students and to undergraduate honors students.